Premium
EFFECTS OF POMC‐DERIVED PEPTIDES ON ALDOSTERONE SECRETION IN VIVO
Author(s) -
McDougall John G.,
Murphy Gregory J.,
Coghlan John P.,
Denton Derek A.,
Hardy Kenneth J.,
Johnson Elizabeth I. M.,
Scoggins Bruce A.,
Wright R. Douglas
Publication year - 1987
Publication title -
clinical and experimental pharmacology and physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 103
eISSN - 1440-1681
pISSN - 0305-1870
DOI - 10.1111/j.1440-1681.1987.tb01889.x
Subject(s) - aldosterone , endocrinology , medicine , secretion , in vivo , peptide hormone , hormone , chemistry , melanocyte stimulating hormone , peptide , biology , biochemistry , microbiology and biotechnology
SUMMARY 1. To investigate a role for peptides derived from the precursor molecule pro‐ opiomelanocortin (POMC) on the control of aldosterone secretion (ASR), α‐, β‐, γ 1 , and γ 2 ‐melanocyte stimulating hormone (MSH), corticotropin‐like intermediate lobe peptide (CLIP) or β‐endorphin were infused into the adrenal arterial supply of sheep with an adrenal cervical autotransplant. 2. None of the peptides had any significant effect on aldosterone secretion rate in Na replete, unstressed, conscious animals. In contrast, ACTH‐stimulated ASR approximately twofold. 3. POMC‐derived peptides other than ACTH appear to have little or no effect on the short‐term control of aldosterone secretion in vivo , although a role in control and modulation of adrenal function over the longer term cannot be discounted.